Innovation Pharmaceuticals (OTCMKTS:IPIX) Trading 0.8% Higher

Innovation Pharmaceuticals Inc. (OTCMKTS:IPIX) shares shot up 0.8% during trading on Wednesday . The stock traded as high as $0.23 and last traded at $0.22. 858,737 shares traded hands during trading, a decline of 57% from the average session volume of 1,987,154 shares. The stock had previously closed at $0.22.

The firm has a 50-day simple moving average of $0.22.

Innovation Pharmaceuticals Company Profile (OTCMKTS:IPIX)

Innovation Pharmaceuticals Inc, a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. It develops Brilacidin, a lead drug compound for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19.

Featured Article: Lock-Up Period Expiration

Receive News & Ratings for Innovation Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovation Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.